10.1016/j.jcf.2022.01.009 82 HalbeisenF
NAD+ n = 8 and Control n = 3) aged 30-55 years had their safety of IV infusion of NAD+ evaluated using liver function tests (serum, total bilirubin, alkaline phosphatase, alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, and aspartate aminotransferase (10)
Reconstituted peptide stability depends on storage conditions, with refrigeration at appropriate temperatures critical for maintaining activity
Multiple factors made Amino Asylum a priority target: marketing products explicitly for human consumption, selling prescription medications without authorization, using trademarked pharmaceutical terms in advertising, ignoring FDA warning letters, and operating at a scale that made the public health risk significant